Maria Korontzi Selected Research

Lenograstim

1/2019

Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Korontzi Research Topics

Disease

2	Colitis 01/2019 - 01/2018
2	Inflammation (Inflammations) 01/2018 - 10/2012
2	Reperfusion Injury 01/2015 - 04/2014
2	Ischemia 01/2015 - 04/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Aberrant Crypt Foci 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Necrosis 04/2014
1	Hemorrhage 04/2014
1	Edema (Dropsy) 04/2014
1	Appendicitis 10/2012

Drug/Important Bio-Agent (IBA)

2	U 74389FIBA 01/2015 - 04/2014
1	molgramostimIBA 01/2019
1	sargramostim (Leukine)FDA Link 01/2019
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019
1	LenograstimIBA 01/2019
1	AcidsIBA 01/2019
1	PrebioticsIBA 01/2018
1	Malondialdehyde (Propanedial)IBA 04/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2014
1	Therapeutic UsesIBA 04/2014

Therapy/Procedure

1	Intravenous Injections 04/2014
1	Length of Stay 10/2012